TD Private Client Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $960K | Buy |
7,592
+4,636
| +157% | +$587K | 0.02% | 373 |
|
|
2025
Q1 | $378K | Buy |
2,956
+210
| +8% | +$26.9K | 0.01% | 491 |
|
|
2024
Q4 | $363K | Buy |
2,746
+81
| +3% | +$10.7K | 0.01% | 499 |
|
|
2024
Q3 | $388K | Sell |
2,665
-22
| -0.8% | -$3.2K | 0.01% | 485 |
|
|
2024
Q2 | $369K | Sell |
2,687
-321
| -11% | -$44.1K | 0.01% | 479 |
|
|
2024
Q1 | $413K | Sell |
3,008
-494
| -14% | -$67.8K | 0.01% | 472 |
|
|
2023
Q4 | $476K | Sell |
3,502
-1,028
| -23% | -$140K | 0.02% | 444 |
|
|
2023
Q3 | $554K | Sell |
4,530
-221
| -5% | -$27K | 0.02% | 397 |
|
|
2023
Q2 | $603K | Sell |
4,751
-114
| -2% | -$14.5K | 0.03% | 414 |
|
|
2023
Q1 | $628K | Sell |
4,865
-157
| -3% | -$20.3K | 0.03% | 400 |
|
|
2022
Q4 | $659K | Sell |
5,022
-119
| -2% | -$15.6K | 0.03% | 384 |
|
|
2022
Q3 | $601K | Buy |
5,141
+100
| +2% | +$11.7K | 0.03% | 383 |
|
|
2022
Q2 | $593K | Sell |
5,041
-311
| -6% | -$36.6K | 0.03% | 388 |
|
|
2022
Q1 | $697K | Sell |
5,352
-8,644
| -62% | -$1.13M | 0.03% | 387 |
|
|
2021
Q4 | $2.14M | Buy |
13,996
+317
| +2% | +$48.4K | 0.09% | 225 |
|
|
2021
Q3 | $2.21M | Sell |
13,679
-1,646
| -11% | -$266K | 0.09% | 216 |
|
|
2021
Q2 | $2.51M | Buy |
15,325
+146
| +1% | +$23.9K | 0.11% | 200 |
|
|
2021
Q1 | $2.29M | Buy |
15,179
+6,013
| +66% | +$905K | 0.11% | 204 |
|
|
2020
Q4 | $1.39M | Buy |
9,166
+5,383
| +142% | +$815K | 0.07% | 268 |
|
|
2020
Q3 | $512K | Buy |
+3,783
| New | +$512K | 0.03% | 354 |
|